Mary Ann Liebert, Inc. - Human Gene Therapy

This paper was cited by:

Vaccinia as a vector for gene delivery

Z Sheng Guo, David L Bartlett

Expert Opinion on Biological Therapy. Jul 2004, Vol. 4, No. 6: 901-917

Use of suicide genes for cancer gene therapy: study of the different approaches

G Vassaux, P Martin-Duque

Expert Opinion on Biological Therapy. May 2004, Vol. 4, No. 4: 519-530

Immunomodulatory gene therapy for haematological malignancies

G. D. Schmidt-Wolf, I. G. H. Schmidt-Wolf

British Journal of Haematology. May 2002, Vol. 117, No. 1: 23-32

Optimization of retroviral vector generation for clinical application

Andrea J. Schilz, Klaus K

hlcke, Axel A. Fauser, Hans-Georg Eckert

The Journal of Gene Medicine. Oct 2001, Vol. 3, No. 5: 427-436

Progress in antiangiogenic gene therapy of cancer

Andrew L. Feldman, Steven K. Libutti

Cancer. Oct 2000, Vol. 89, No. 6: 1181-1194

Immunomodulation of cancer: potential use of selectively replicating agents

Siamak Agha-Mohammadi, Michael T. Lotze

Journal of Clinical Investigation. Jun 2000, Vol. 105, No. 9: 1173-1176